[
  {
    "ts": "2026-01-24T19:10:16+00:00",
    "headline": "Is It Time To Reconsider Humana (HUM) After Mixed Returns And DCF Upside?",
    "summary": "If you are wondering whether Humana is reasonably priced at around US$266.50 a share, you are not alone, as many investors are asking the same question about what they are really paying for. The stock is roughly flat so far in 2026 with a 0.8% return year to date. It currently sits between a 2.5% decline over the last 7 days and a 2.8% gain over the last 30 days, while the 1 year return of 8.3% and 3 year return of 42.8% highlight how sentiment has shifted over time. Recent news around large...",
    "url": "https://finance.yahoo.com/news/time-reconsider-humana-hum-mixed-191016943.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7ec15959-a2c7-359f-90d9-434ec8520b64",
      "content": {
        "id": "7ec15959-a2c7-359f-90d9-434ec8520b64",
        "contentType": "STORY",
        "title": "Is It Time To Reconsider Humana (HUM) After Mixed Returns And DCF Upside?",
        "description": "",
        "summary": "If you are wondering whether Humana is reasonably priced at around US$266.50 a share, you are not alone, as many investors are asking the same question about what they are really paying for. The stock is roughly flat so far in 2026 with a 0.8% return year to date. It currently sits between a 2.5% decline over the last 7 days and a 2.8% gain over the last 30 days, while the 1 year return of 8.3% and 3 year return of 42.8% highlight how sentiment has shifted over time. Recent news around large...",
        "pubDate": "2026-01-24T19:10:16Z",
        "displayTime": "2026-01-24T19:10:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f6ed28f0d41f879bd5a978786002c2db",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Hmp2bSpG9df53vmcWkUJ8g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f6ed28f0d41f879bd5a978786002c2db.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KUEpq9U8lIeW2zfadEuUSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f6ed28f0d41f879bd5a978786002c2db.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/time-reconsider-humana-hum-mixed-191016943.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/time-reconsider-humana-hum-mixed-191016943.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HUM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]